Eliminating cervical cancer in the COVID-19 era

Ophira Ginsburg¹, Partha Basu², Sharon Kapambwe³, Karen Canfell^{4

5}

Affiliations

¹ Section for Global Health, Department of Population Health and Perlmutter Cancer Center, NYU Grossman School of Medicine, NYU Langone Health, New York, NY, USA. ophira.ginsburg@nyulangone.org.
² International Agency for Research on Cancer, Lyon, France.
³ Ministry of Health, Lusaka, Zambia.
⁴ Cancer Council New South Wales, Sydney, Australia.
⁵ Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Ophira Ginsburg et al. Nat Cancer. 2021 Feb.

. 2021 Feb;2(2):133-134.

doi: 10.1038/s43018-021-00178-9.

Ophira Ginsburg¹, Partha Basu², Sharon Kapambwe³, Karen Canfell^{4

5}

¹ Section for Global Health, Department of Population Health and Perlmutter Cancer Center, NYU Grossman School of Medicine, NYU Langone Health, New York, NY, USA. ophira.ginsburg@nyulangone.org.
² International Agency for Research on Cancer, Lyon, France.
³ Ministry of Health, Lusaka, Zambia.
⁴ Cancer Council New South Wales, Sydney, Australia.
⁵ Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

No abstract available

References

1. World Health Organization. Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem (World Health Organization, Geneva, 2020).
1. Simms, K. T. et al. Lancet Oncol. 20, 394–407 (2019). - DOI - PubMed
1. Hall, M. T. et al. Lancet Public Health 4, e19–e27 (2019). - DOI - PubMed
1. Burger, E. A. et al. Lancet Public Health 5, e213–e222 (2020). - DOI - PubMed - PMC
1. Canfell, K. et al. Lancet 395, 591–603 (2020). - DOI - PubMed - PMC